| The pancreatic islet: What we know 150 years after Langerhans |
2 |
| Simplicity and Complexity in Medicine |
2 |
| Diagnostic and therapeutic management of uveitis |
1 |
| Autologous stem cell transplantation in hematology: Historical review and possible revival for the treatment of acute myelogenous leukemia |
1 |
| Cost of anticancer drugs: a challenge for health systems of OCDE countries |
1 |
| CAR-T cells for childhood and adult Acute Lymphoblastic Leukemia |
1 |
| Artificial intelligence and medical imaging: Definition, state of the art and perspectives |
1 |
| Risks of severe hyponatremia in children receiving hypotonic intravenous fluids |
1 |
| Jurisprudential definition of nosocomial infections, in support of eleven decisions of the Conseil d'Etat |
1 |
| The Olympic Games, fight against doping and equity maintenance |
1 |
| France's place in industrial promotion clinical trials |
1 |
| Allogeneic CAR T-Cells (UCART) |
1 |
| CAR-T cells management in french hospitals: manufacturing, distribution, and regulatory aspects |
1 |
| Child and adolescent, targets of the tobacco industry |
1 |
| Changes and innovations in traumatology/orthopaedics |
0 |
| Risks associated to maternal smoking during pregnancy. Special attention to post-natal risks |
0 |
| Tobacco and children: Birth of an addiction |
0 |
| Pregnancy, child and passive smoking |
0 |
| Psychoactive substance use in prison and associated risks |
0 |
| In prison with schizophrenia |
0 |
| Motherhood in prison |
0 |
| Extracellular vesicles: new therapeutic agents for cardiac repair ? |
0 |
| Monoclonal antibodies to treat cancer: initiate an immune response besides a specific tumor regression |
0 |
| Interventional radiology in bone metastasis |
0 |
| Medical response to major disasters |
0 |
| DNA microarrays and new microdeletion syndromes |
0 |
| Impact of the perinatal care organization |
0 |
| Toward a preventive approach of Alzheimer's disease ? |
0 |
| The departure of doctors with degrees outside the European Union in the medical demography in France since 10 years |
0 |
| Contribution of biomechanics of impact in injury prevention |
0 |
| Subject specific numerical simulation and its application to traumatology |
0 |
| Patent foramen ovale, atrial septal aneurysm and cryptogenic stroke: the CLOSE trial |
0 |
| Intestinal tuft cells : from type-2 immune response to carcinogenesis |
0 |
| Assessment of medical aptitude to drive: what are the stakes? |
0 |
| Home Dialysis: is patient autonomy for an artificial organ possible? |
0 |
| Are hemodialysis monitors become intelligent? |
0 |
| Multimorbidity: Clinical practice by the general practitioner |
0 |
| Telemedicine applied to hemodialysis or connected machine |
0 |
| Back to normal life after cancer treatment |
0 |
| Prices of cancer drugs in France: pricing system and determining factors |
0 |
| Are depressed patients too aware of others? The contribution of cerebral imaging to major depression physiopathology |
0 |
| Multiple myeloma biology: clinical utility |
0 |
| From the radiographic skeletal survey to whole body MRI: 30 year-advances in imaging of multiple myeloma |
0 |
| Is curing myeloma feasible in the near future? |
0 |
| Diabetes mellitus and heart failure: epidemiology and therapeutic implications |
0 |
| Targeted therapies in inflammatory skin diseases |
0 |
| Implementing TIA clinics in France ? Do not they already exist? |
0 |
| Establishing TIA clinics in France, a public health need |
0 |
| Endocrine and metabolic effects of anticancer immunotherapies (according to the recommendations of the French Society of Endocrinology) |
0 |
| Biological treatments of chronic inflammatory rheumatic diseases: clinical results |
0 |
